What are the recent trends in market size and growth for the hydronephrosis market?
The hydronephrosis market size has grown rapidly in recent years. It will grow from $3.06 billion in 2024 to $3.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing prevalence of kidney stones, rising incidence of urinary tract infections, growth in the geriatric population, increasing awareness and early diagnosis, and rising healthcare expenditure.
The hydronephrosis market size is expected to see rapid growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the increasing prevalence of chronic kidney diseases, rising adoption of minimally invasive surgeries, growing awareness about early detection, expansion of healthcare infrastructure, and development of new treatment options. Major trends in the forecast period include growth in personalized medicine, increasing use of artificial intelligence in diagnostics, advancements in non-invasive treatment methods, rise in patient-centric healthcare approaches, and integration of telemedicine in nephrology.
Get Your Free Sample of The Global Hydronephrosis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20563&type=smp
How have varous drivers impacted the growth of the hydronephrosis market?
The rising prevalence of kidney diseases is expected to propel the growth of the hydronephrosis market going forward. Kidney disease, also known as renal disease or nephropathy, refers to a range of conditions that result in damage to the kidneys, impairing their ability to filter blood effectively. The increasing cases of kidney diseases are due to several factors, such as the rising incidence of diabetes and hypertension, obesity, the aging population, and genetic and ethnic factors. Hydronephrosis is treated by addressing the underlying cause of the urinary obstruction, which may involve medications, surgery, or other interventions to restore normal urine flow. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, currently, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the rising prevalence of kidney diseases is driving the growth of the hydronephrosis market.
What are the primary segments of the hydronephrosis market?
The hydronephrosis market covered in this report is segmented –
1) By Type: Unilateral Hydronephrosis, Bilateral Hydronephrosis
2) By Indication: Intrinsic, Extrinsic
3) By Diagnosis: Laboratory Test, Imaging
4) By Treatment: Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Other Treatments
Subsegments:
1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis, Acquired Unilateral Hydronephrosis, Obstructive Unilateral Hydronephrosis, Non-Obstructive Unilateral Hydronephrosis
2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis, Acquired Bilateral Hydronephrosis, Obstructive Bilateral Hydronephrosis, Non-Obstructive Bilateral Hydronephrosis
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/hydronephrosis-global-market-report
Which firms are leading the hydronephrosis market?
Major companies operating in the hydronephrosis market are AbbVie Inc., Boston Scientific Corporation, Novartis AG, 3M Company, F. Hoffmann-La Roche Ltd, Medtronic PLC, Amgen Inc., Stryker Corporation, Thermo Fisher Scientific Inc., B. Braun Group, Terumo Interventional Systems, Sigma-Aldrich Co, Coloplast A/S, Cook Medical, KARL STORZ SE & Co. KG, Spire Healthcare Group plc, Promega Corporation, NantHealth Inc., UroGen Pharma Ltd., Natus Medical Incorporated, Renal Associates P.A., Urologix Inc., Savant Medical Group
How will industry trends affect the trajectory of the hydronephrosis market?
Major companies operating in the hydronephrosis market are developing innovative products such as drainage catheters to enhance patient care by providing efficient and minimally invasive solutions for draining urine from the kidneys. Drainage catheters are medical devices used to remove fluids, such as urine or blood, from the body to relieve pressure or prevent fluid accumulation. For instance, in October 2024, Argon Medical Devices Inc. is a US-based manufacturer of specialty medical products, launched the SKATER mini-loop drainage catheter. This catheter is a medical device designed for the minimally invasive drainage of unwanted fluid collections in the body. It is inserted through the skin using imaging guidance and features a loop that is 40% smaller, ensuring secure placement and effective drainage from smaller cavities. Known for its durability, kink resistance, and compatibility with alcohol, this catheter enhances usability in interventional procedures. By expanding Argon’s drainage portfolio, the SKATER Mini-Loop aims to improve patient outcomes and streamline the drainage process for healthcare professionals.
Which geographic trends are shaping the hydronephrosis market, and which region has the highest market share?
North America was the largest region in the hydronephrosis market in 2024. The regions covered in the hydronephrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Hydronephrosis Market Report 2025 Offer?
The hydronephrosis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Hydronephrosis is a medical condition characterized by the swelling of one or both kidneys due to a buildup of urine. This occurs when the flow of urine is obstructed, causing the kidneys to become enlarged. It can result from blockages such as kidney stones, tumors, or anatomic abnormalities, and may lead to kidney damage if left untreated.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20563
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
